Virtus ETF Advisers LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 145 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.9%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$132,665
-57.9%
121,711
-11.5%
0.08%
-56.7%
Q2 2023$314,761
+283.9%
137,450
+250.1%
0.19%
+405.4%
Q1 2022$82,000
-50.0%
39,262
-5.6%
0.04%
-40.3%
Q4 2021$164,000
-23.0%
41,584
-6.3%
0.06%
-34.0%
Q3 2021$213,000
-0.5%
44,378
-5.0%
0.09%
+6.8%
Q2 2021$214,000
-9.3%
46,699
-61.4%
0.09%
-9.3%
Q1 2020$236,000
-56.7%
121,070
-7.8%
0.10%
+9.0%
Q4 2019$545,000
+47.7%
131,286
+7.0%
0.09%
+20.3%
Q3 2019$369,000
-59.0%
122,654
-14.4%
0.07%
-61.1%
Q2 2019$901,000
+65.0%
143,272
+74.1%
0.19%
+104.3%
Q4 2018$546,000
-15.7%
82,295
+35.5%
0.09%
+38.8%
Q3 2018$648,000
-4.7%
60,728
+7.2%
0.07%
-88.9%
Q2 2018$680,000
-11.7%
56,636
-37.0%
0.60%
-10.0%
Q1 2018$770,000
-18.0%
89,845
-5.5%
0.67%
-43.3%
Q4 2017$939,000
+292.9%
95,079
+388.3%
1.18%
+3581.2%
Q3 2017$239,000
-17.9%
19,472
+10.1%
0.03%
-25.6%
Q2 2017$291,000
+11.9%
17,691
-2.5%
0.04%
-6.5%
Q1 2017$260,000
+14.5%
18,150
+10.6%
0.05%
-32.4%
Q4 2016$227,000
-28.8%
16,410
-7.0%
0.07%
-55.8%
Q3 2016$319,000
+26.1%
17,6490.0%0.15%
-18.1%
Q2 2016$253,000
+10.0%
17,649
-8.4%
0.19%
-40.7%
Q1 2016$230,000
-15.8%
19,267
-6.0%
0.32%
-57.7%
Q4 2015$273,00020,4860.75%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders